Lior C, Barki D, Halperin C, Iacobuzio-Donahue C, Kelsen D, Shouval R
Cell Rep. 2024; 43(5):114236.
PMID: 38758650
PMC: 11156623.
DOI: 10.1016/j.celrep.2024.114236.
Mouawad N, Capasso G, Ruggeri E, Martinello L, Severin F, Visentin A
Biomolecules. 2023; 13(4).
PMID: 37189352
PMC: 10135835.
DOI: 10.3390/biom13040604.
Moscvin M, Ho M, Bianchi G
Cancer Drug Resist. 2022; 4:1028-1046.
PMID: 35265794
PMC: 8903187.
DOI: 10.20517/cdr.2021.93.
Virdis P, Migheli R, Bordoni V, Fiorentino F, Sanna L, Marchesi I
Int J Mol Med. 2021; 48(6).
PMID: 34643251
PMC: 8522960.
DOI: 10.3892/ijmm.2021.5046.
Manni S, Fregnani A, Barila G, Zambello R, Semenzato G, Piazza F
Front Oncol. 2020; 10:802.
PMID: 32500036
PMC: 7243738.
DOI: 10.3389/fonc.2020.00802.
HSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways.
Xu F, Lin D, Jiang W, Meng L, Xu Y, Wang C
Int J Clin Exp Pathol. 2020; 12(7):2585-2594.
PMID: 31934086
PMC: 6949580.
Genomewide identification and analysis of heat-shock proteins 70/110 to reveal their potential functions in Chinese soft-shelled turtle .
Liu T, Han Y, Liu Y, Zhao H
Ecol Evol. 2019; 9(12):6968-6985.
PMID: 31467669
PMC: 6712388.
DOI: 10.1002/ece3.5264.
Evaluation of [C]NMS-E973 as a PET tracer for visualisation of HSP90.
Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K
Theranostics. 2019; 9(2):554-572.
PMID: 30809293
PMC: 6376183.
DOI: 10.7150/thno.27213.
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
Fok J, Hedayat S, Zhang L, Aronson L, Mirabella F, Pawlyn C
Clin Cancer Res. 2018; 24(10):2395-2407.
PMID: 29391353
PMC: 6420136.
DOI: 10.1158/1078-0432.CCR-17-1594.
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma.
Eugenio A, Fook-Alves V, De Oliveira M, Fernando R, Zanatta D, Strauss B
Oncotarget. 2018; 8(70):114698-114709.
PMID: 29383113
PMC: 5777725.
DOI: 10.18632/oncotarget.22815.
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
Crawford L, Anderson G, Johnston C, Irvine A
Oncotarget. 2016; 7(43):70481-70493.
PMID: 27655696
PMC: 5342567.
DOI: 10.18632/oncotarget.12026.
Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets.
Fernando R, de Carvalho F, Mazzotti D, Evangelista A, Braga W, Chauffaille M
Genes Cancer. 2016; 6(11-12):462-471.
PMID: 26807199
PMC: 4701225.
DOI: 10.18632/genesandcancer.88.
Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress.
Cheng Z, Teo G, Krueger S, Rock T, Koh H, Choi H
Mol Syst Biol. 2016; 12(1):855.
PMID: 26792871
PMC: 4731011.
DOI: 10.15252/msb.20156423.
Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
Jheng H, Tsai P, Chuang Y, Shen Y, Tai T, Chen W
Dis Model Mech. 2015; 8(10):1311-21.
PMID: 26398934
PMC: 4610229.
DOI: 10.1242/dmm.019398.
Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment.
Shervington L, Patil H, Shervington A
J Cancer. 2015; 6(8):786-94.
PMID: 26185541
PMC: 4504115.
DOI: 10.7150/jca.12251.
Efficacy of the HSP70 inhibitor PET-16 in multiple myeloma.
Bailey C, Budina-Kolomets A, Murphy M, Nefedova Y
Cancer Biol Ther. 2015; 16(9):1422-6.
PMID: 26176532
PMC: 4622955.
DOI: 10.1080/15384047.2015.1071743.
Novel therapeutic strategies for multiple myeloma.
Mimura N, Hideshima T, Anderson K
Exp Hematol. 2015; 43(8):732-41.
PMID: 26118499
PMC: 4540643.
DOI: 10.1016/j.exphem.2015.04.010.
Investigations of interferon-lambda for the treatment of cancer.
Stiff A, Carson III W
J Innate Immun. 2015; 7(3):243-50.
PMID: 25661266
PMC: 6738825.
DOI: 10.1159/000370113.
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
Wada N, Kawano Y, Fujiwara S, Kikukawa Y, Okuno Y, Tasaki M
Int J Oncol. 2014; 46(3):963-72.
PMID: 25530098
PMC: 4324584.
DOI: 10.3892/ijo.2014.2804.
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.
Mirabella F, Murison A, Aronson L, Wardell C, Thompson A, Hanrahan S
PLoS One. 2014; 9(6):e99493.
PMID: 24923560
PMC: 4055699.
DOI: 10.1371/journal.pone.0099493.